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The purpose of this paper is to explore the possibilities of treating the contents 
of the blood stream as a hemolytic system in which a more or less steady state is 
maintained  by  the  production of new  red  cells  to  replace  those  which  are 
destroyed.  The attempt will raise both new  questions  and  questions which 
have been the subject of investigation already, and I realize that it will often do 
no more than outline the problems still to be solved.  In their essentials, these 
problems are those of the nature of the in vivo lysins, the nature of their ac- 
celerators  and  inhibitors,  the  rules  which  apply  to  the  mixtures  of  lysins, 
accelerators, and inhibitors which compose the in vivo hemolytic systems, and 
the kinetics which describe the way in which red cell destruction by the hemo- 
lytic mixtures is balanced by the production of new red  cells. 
1.  The Lyric Effect of Mixtures of Lysins, Accderators,  and Inhibitors 
In vivo hemolytic systems consist of mixtures of many lysins, accelerators, 
and inhibitors, and relations must exist between the hemolytic activity of these 
mixtures and the activity of the lysins acting singly, accelerated or inhibited by 
individual  accelerators and  inhibitors.  One  would  expect  the  effect of  the 
individual  components  to  be  approximately  additive,  although  reactions 
between them might enhance or depress their activities.  This is what seems 
to occur in mixtures of lysins (Ponder,  1933). 
Two types of experiment are suitable for studying the combined effects of 
lysins,  accelerators, and  inhibitors.  In  the  first  the effects are  obtained  in 
systems in which lysis occurs in short times, while the second applies to systems 
more closely resembling in vivo systems, in which the lysin exists in small and 
nearly asymptotic concentration. 
1.  A standard time-dilution curve is obtained at 37°C. for systems containing 
0.8 ml. of lysin, 0.8 nil. of 1 per cent NaC1 (saline), and 0.4 ml. of red cell sus- 
pension (the thrice washed cells of 1 ml. of blood suspended in 20 ml. of saline). 
Systems in which the accelerators or inhibitors are present in various amounts 
are then prepared e.g., a  system might contain 0.8 ml. of lysin, 0.4 ml. of an 
accelerator, 0.4 ml. of saline, and 0.4 ml. of cell suspension.  If c, is the con- 
centration of lysin in the standard system which takes the same time for com- 
plete hemolysis as a  concentration ca in the system containing the accelerator, 
or cl in the system containing the inhibitor, ca~c, =  R~ for the accelerator, and 
cdc, --~  R~ for the inhibitor. 
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Systems containing both the accelerator and the inhibitor can be prepared 
by taking 0.8 ml. of lysin, 0.4 ml. of the accelerator, 0.4 ml. of the inhibitor, and 
adding 0.4 ml.  of the cell suspension.  The  effect of the accelerator and the 
inhibitor  acting  together  is  expressed,  by  reference  to  the  standard  time- 
dilution curve, as R~.  Innumerable ways will suggest themselves for combin- 
ing accelerators and inhibitors in systems which are comparable to standard 
systems.  The general problem is whether R~ is  the same as the calculated 
net effect of the individual effects R~ and R~, which, because of the way in which 
R is measured, is equal to (R~)(R~). 
Table I  shows the result of a typical experiment at 37°C. in which the lysin 
is saponin, the accelerator 1 rn~/1, indol, and the inhibitor plasma diluted 1 in 
100.  In  this  system  the  correspondence between R~i  and  (Ra)(R~) is  quite 
good, although the component of acceleration seems to be favored, especially 
TABLE I 
Saponln 1  in 
t0,000 
15,000 
20,000 
25,000 
30,000 
35,000 
Accelerator and inhibitor 
Indol, 1 m~/1., 0.4 ml. 
Plasma 1/100, 0.4 ml. 
Indol, 1 m:~/l., 0.2 ml. 
Plasma 1/1000, 0.2 ml. 
Indol, 1 mM/1., 0.2 ml. 
Plasma 1/100, 0.05 ml. 
•a 
0.70 
0.73 
0.70 
0.76 
0.78 
0.74 
Ri  Rag  .l~lc. 
1.70  1.9~  1.19 
1.67  I  1.0~  1.22 
1.60  1.0(  1.12 
1.27  0.9I  0.96 
1.27 
1.14 
0.9.: 
0.84 
0.99 
0.85 
in the systems in which lysis is rapid.  This may be due to some such effect as 
the accelerator being more rapidly concentrated at the cell surfaces than the 
inhibitor.  Speaking generally, the results obtained by this method are the same 
as those obtained by the method next to be described, which measures the values 
of Ra, R~,  and Ral at  the asymptotes of the respective time-dilution curves. 
2.  The asymptote of the standard time-dilution curve is found in the usual 
way for systems containing 0.8 ml. of lysin, 0.8 ml. of saline, and 0.4 ml. of red 
cell suspension.  In a similar way, the asymptotes are found for  (a) a system 
containing 0.8 ml. of lysin in various dilutions, 0.4 ml. of an accelerator, 0.4 
ml. of saline, and 0.4 ml. of suspension, and (b) a system containing 0.8 ml.  of 
lysin, 0.4 ml. of inhibitor, 0.4 ml. of saline,  and 0.4 ml. of suspension.  For 
practical purposes,  the concentration of ]ysin which produces complete lysis 
in 300 minutes may be taken as the asymptotic concentration.  The position 
of these two asymptotes and that for the standard curve determines R~ and R~. 
A series of systems containing 0.8 ml. of lysin, 0.4 ml. of accelerator, 0.4 ml. of 
inhibitor, and 0.4 ml. of cell suspension is then set up, and the asymptote for ERIC PONDER  485 
the time-dilution curve is found.  This gives R~¢.  Table II shows the results 
for three experiments of this kind. 
When we take these results together with others (accelerators, Ponder, 1941 ; 
inhibitors, Ponder, 1943; and mixed lysins, Ponder, 1933)  I  think that it can 
be said  that  the behavior of mixtures of accelerators, inhibitors,  and lysins 
is  fairly well  established, provided  that  the  systems  are  relatively simple. 
The net effects can usually be obtained by appropriate calculations in terms 
of R-values,  although  sometimes  enhancement  or  partial  neutralization  of 
effects occurs.  When dealing with hemolysins in vivo, however, we are dealing 
with a  mixture of unknown lysins, and in the case of any one inhibitory or 
acceleratory substance the question must always arise as to whether its effect 
on an in vitro system containing lysins such as saponin, a bile salt, or a soap, is 
any guide to its effect on the  in  vivo  system  of unknown  composition.  At 
present  there is no way of answering  this  question except by direct experi- 
TABLE II 
Lysin 
Saponin 
Taurocholate 
Oleate 
Accelerator  and inhibitor  Ra  Ri  Ra~  P,~o, 
Indol, 1 m~/1., 0.4 ml.  0.75  3.0  2.14  2.25 
Plasma 1/100, 0.4 ml. 
Same  0.33  1.5  [ 0.50  ] 0.50 
Same  [0.30  I  2.5  [0.75[0.70 
meat, which must take the form of seeing whether the substance increases or 
decreases red cell destruction in the intact animal.  In the few cases in which 
the experiments have been done  (e.g.,  indol, by Rhoads  and  his  collabora- 
tors,  1938;  phenothiazine, by Collier and Allen, 1942;  quinine, by Ponder and 
Abels,  1936) the substances which were found to be accelerators in vitro were 
found to be accelerators in vivo also. 
II.  The Nature of the Intravascular Lysins 
Principally because of Rous and Robertson's  observation (1917)  that frag- 
mentation plays such an important part in red cell destruction in vivo, evidence 
for the existence of intravascular lysins in normal blood has been less energeti- 
cally sought than it might have been.  Rous says "At the present time (1923) 
the thesis that hemolysis is concerned in normal  blood destruction must be 
looked upon as unproven  ....  Only two methods have so far been discovered 
whereby worn out cells leave the circulation, namely, phagocytosis and frag- 
mentation  ....  Both processes may quite possibly be of little importance as 
compared with some other unrecognized as yet.  One is privileged to believe 
as  one wishes  about  the  matter,  but  scarcely to  draw  conclusions."  Even 
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by lytic processes is not  very impressive as  long as  we confine ourselves to 
normal material; if evidence obtained from pathological material is admitted, 
on the other hand,  there never has been much doubt about  the matter  (see 
Rous's review).  The weight of the evidence will appear greater, moreover, if 
we bear in mind that hemolytic processes may exist in vivo although the normal 
method of red  cell destruction is fragmentation and phagocytosis.  Suppose 
that  the  effective concentration of intravascular lysis is  cl  and  that  in  this 
concentration lysis would take 50 days.  If there is a simultaneous process of 
fragmentation by means of which red cell destruction is effected in 30 days, 
fragmentation will appear as the method of normal destruction, although the 
slower process of lysis is operating all the time.  If the concentration cl were 
to double, however, the new concentration c2 might be able to produce lysis 
in 25 days, and the destruction of the cells by the hemolytic process would occur 
before the destruction by fragmentation.  Fragmentation and phagocytosis as 
the usual methods of red cell destruction are thus by no means incompatible 
with the continual operation of in vivo lysins, the effects of which may become 
prominent if their concentration increases. 
The three normal in vivo hemolytic processes for which there is substantial 
evidence involve (1) the action of the soaps in chyle after a  meal rich in fat, 
(2) the action of the spleen in modifying red cells so as to aid in their destruc- 
tion, and  (3)  the hemolytic effect of substances derived from tissues such as 
lung, liver, and spleen. 
1.  Freeman  and  Johnson  (1940),  and  Loewy,  Freeman,  Marchello,  and 
Johnson  (1943), have shown that the soap content of the chyle rises to 3  to 
6 rag. per ml. during rapid fat absorption, and that  this quantity of soap is 
sufficient to bring about a certain amount of hemolysis when it enters the blood 
stream.  During fasting, soaps are found in amounts too small to cause experi- 
mentally demonstrable hemolysis, but when the individual is eating an ordinary 
diet their continual action probably provides a normal mechanism for red cell 
destruction.  Again  it should be emphasized that  the important  thing from 
the standpoint of this discussion is the existence of the in vivo hemolytic system, 
even although the concentration of lysin in it is not sufficient to hemolyze a 
single cell before the cell's life is terminated by other processes (fragmentation, 
phagocytosis, etc.).  If the hemolytic system exists normally, there are always 
the  possibilities  (a)  that  the  concentration  of lysin  will  increase  and  that 
intravascular lysis will become an important mode of cell destruction, and (b) 
that in the presence of an accelerator, or because of the reduction in the con- 
centration of an inhibitor,  the  lysin will become more effective than it was 
previously.  Whenever one can show that an increase in the concentration of a 
normally occurring blood constituent results in intravascular hemolysis, I think 
that one can assume that a  normal in vivo hemolytic system exists; Johnson 
and his  collaborators have done this for the soaps,  and by the same sort of ERIC  PONDER  487 
reasoning there is satisfactory evidence for the existence of a hemolytic system 
containing the bile salts. 
2.  The evidence for the spleen being an organ in which red ceils are destroyed 
or prepared for destruction has been reviewed by Rous (1923), by Krumbhaar 
(1926), and more recently by Dameshek (1941,  1942).  The frequent observa- 
tion that red cell resistance to certain forms of lysis is increased in vitro after 
splenectomy  was  shown  by  Gordon  and  Kleinberg  (1937)  to  correspond 
to  an  increased  resistance  to  destruction  in  vivo  in  the guinea pig,  and  the 
increased resistance to hypotonic saline is due to the cell being able to attain a 
greater volume before it hemolyzes  (Gordon,  Kleinberg,  and  Ponder,  1937). 
The removal of the spleen is accordingly followed by an alteration in the struc- 
ture  of  the  red  cell,  and  the  increase  in  resistance  to  lysis by  taurocholate 
(although not to lysis by saponin) points to the same conclusion.  After splenec- 
tomy in man the alteration in structure is accompanied by a  change in shape, 
the red  cell population  containing  an increased number of flat cells  ("platy- 
cytes," some of which may even be "target cells," Singer, Miller, and Dameshek, 
1941).  The reason for these shape changes is still  obscure,  but according to 
the view which prevails at the moment, the spleen produces substances which 
tend to make red cells less fiat and more spheroidal, the continued action of 
which may eventually produce spheres and hemolysis.  Removal of the spleen 
with its spherocyte-producing substances thus  results in a  less spheroidal,  or 
flatter,  population. 1  The  possible  nature  of  these  substances  has  been  dis- 
1 An extreme statement of this point of view would be that the red cell is originally 
produced as a very fiat body ("platycyte") with an a/b ratio of, say, 6 to 1, that ~s a 
result of the continued action of substances produced by the spleen and perhaps  by 
other tissues it "tends to spherocytosis" by becoming less and less eccentric as it grows 
older, and it finally becomes a spherocyte and hemolyzes.  The whole process would 
have to take weeks, starting in the marrow where the youngest red cells, although not 
yet in circulation,  would  nevertheless be exposed to the action of circulating lysins, 
and the mean diameter and thickness of the cell as ordinarily measured would corre- 
spond to the diameter and thickness of the cell of mean age, thinner cells being younger 
and thicker cells older.  So far as the kinetics of intravascular hemolysis are con- 
cerned,  there is no objection to this hypothesis, which would correspond very well to 
the transformation of S to S r described  in section IV, provided that the cell  shape 
were a function of S or S'.  The objection to it is that lysins do not usually convert red 
cells into spheres with a  series  of biconcave forms of varying eccentricity as inter- 
mediates.  At least, when studied in vitro,  the intermediates are crenated or thorn- 
apple forms (Ponder, 1935, 1942), and these are not often seen in the circulation.  It 
is possible that a lysin might produce regular forms of diminishing  eccentricity instead 
of crenated forms if it were to act slowly enough, but until such a phenomenon is shown 
to exist the chain of evidence is incomplete.  (Some evidence for it may be found in a 
paper by Tigertt, Duncan, and Hight (1940), but the red cell diameters were measured 
in dried films.)  One might put forward a hypothesis to the effect that the red cell is 488  ltEMOLYSIS  IN  VIVO 
cussed by Singer (1940,  1941), Singer, Miller,  and Dameshek (1941), Ham and 
Castle (1940), and Dameshek and Schwartz (1938).  Bergenhem and Fahraeus 
(1936) have shown that serum contains an enzyme which splits off a substance 
from the serum lipoids after some hours in vitro; this substance can be adsorbed 
on the red cell, and produces a change from the biconcave to the spherical form. 
The enzymatic process proceeds most rapidly at 42°C. and at pH  =  7.2, and 
is inactivated at 56°C.  Bergenhem and Fahraeus have identified the substance 
as  lysolecithin,  small  amounts  of  which  produce  spherocytosis  and  larger 
amounts of which produce hemolysis (cf.  the action of lecithin,  Ponder,  1935, 
1942).  It is possible that the spherocyte-producing substance of the spleen is 
actually lysolecithin3 
3.  Maegraith,  Findlay,  and  Martin  (1943a,  b)  have  recently  described  a 
lytic agent, which they think is an erythrocytase,  in a  variety of human and 
animal  tissues.  Its presence  can be demonstrated  by adding small pieces  of 
washed tissue  to a  washed red cell suspension  and incubating for 24 hours at 
initially a very flat body, that the continued action of lysins from the spleen and else- 
where makes it less and less eccentric, but that fragmentation normally occurs before 
the stage of crenation and sphere formation is reached.  This would account for the 
absence of crenated and spherical cells from normal blood, and only when there was 
an increase in the activity of in ~ivo hemolytic activity might we expect to see circu- 
lating spherical forms and the forms (spheroidal or crenated) preceding them.  This 
would be an interesting working hypothesis, but I  think that it should be borne in 
mind that the spleen may also control the shape of the red cells as produced at their 
source. 
A different mechanism by means of which decreased eccentricity may be produced 
is  that described  by Ham and  Castle  (1940).  Under conditions of stasis,  such as 
probably occur in the spleen, red cells swell as a result of changes in permeability which 
follow on the accumulation of metabolic products, and in swelling they tend to become 
first less eccentric and later spherical.  This change in form is well recognized (Castle 
and Daland, 1937; Ponder, 1937), and is due to quite a different mechanism from that 
responsible for the disk-sphere  transformation  produced  by lysins like lysolecithin. 
While it might be effective in producing red  cell  destruction,  especially if the a/b 
ratio for tile cell is less than normal, it is not necessary to think of it as a mechanism 
which regulates the mean shape of the red cell in the circulating blood. 
2 Great  caution  has  to  be  exercised  in  identifying  substances  extracted  from 
blood and tissue, and the fact that a lyric substance can be extracted cannot be taken 
as evidence that it exists,  as a lysin, in the blood or tissue in vivo.  A great number of 
fatty  acids,  soaps,  and  related  substances  can  be  obtained  by various  extraction 
processes, but before extraction these are probably combined with other tissue com- 
ponents in such a way as to render them non-lytic.  The apparent amount and nature 
of these extractable substances depends on such details as the temperature and pH at 
which the extraction is carried out, and different mixtures of substances, some lyric, 
some inhibitory,  can be obtained by using different concentrations of alcohol; e.g., 
50 per cent, 75 per cent, and so on. ERIC PONDER  489 
37°C.  The lysin is described as being species specific, destroyed by heating 
to 80°C. for 5 minutes, and inhibited by plasma in dilutions as great as 1 in 1000. 
It seems to bear a  relation to the tissue lysins orginally described by Metch- 
nikoff,  of which  an  excellent account was given by Weft in  1907.  Most  of 
Well's work was done with kidney tissue,  freed from blood by perfusion, but 
he also used a variety of tumor tissue, some of which was necrotic.  He found 
that normal tissue,  if chopped up in 10 times its weight of saline and stirred 
for some hours, yields substances in saline extract which are hemolytic for the 
washed red ceils of the same animal (2 hours at 37°C.,  followed by 18 hours 
in the ice box; Well did not ascertain whether the lysin hemolyzed the cells of 
other species as well as the cells of the same species).  Liver and kidney extracts 
were found to contain a  variable amount of lysin, which  is activated by the 
addition of red cell stromata, inhibited by serum, and which can be shown to 
become bound to the surfaces of the red ceils of the system.  Well points out, 
however, that  the  situation  is more complex than appears at first sight,  for 
some of the lytic substances which appear in extracts of incompletely washed 
tissues are derived from the residual blood.  Extracts of non-necrotic tumors 
act hke extracts of normal tissues, but necrotic tissue contains entirely different 
lytic substances in addition.  These are diffusible, and are presumably products 
of necrosis; Well suggests that the frequent anemia which accompanies malig- 
nancy in its later stages may be due in part to the hemolytic action of these 
products of necrosis. 
I  have had  no  difficulty in  confirming Maegraith,  Findlay,  and  Martin's 
results in so far as the lyric effect of pieces of tissue is concerned.  Most of my 
material has been either rat lung or human tissue removed in the operating 
room.  All procedures,  including  the  removal of the  tissue,  must be carried 
out  aseptically)  The tissue is cut  into pieces about 4  mm. by 2 mm., and 
these are washed several times in saline.  Several of the pieces are transferred 
to each of a  series of test tubes, to which 2 ml. of a  suspension of washed red 
ceils are added; the cells may be those of the same species or of another species, 
and buffers, inhibitory agents,  etc.,  can also be added  as the experiment re- 
quires.  The tubes are kept in a water bath at 37°C. with occasional shaking, 
and the results are read after 18 to 24 hours.  Lysis rarely begins before 12 
hours have elapsed, but proceeds fairly rapidly once it starts.  The existence 
3 These experiments must be carried out with the strictest aseptic precautions, and 
the hemolytic systems must be shown to give no growth on blood agar plates at the 
time the results are read.  I have found this degree of sterility very difificult to attain, 
for animal tissues often contain organisms which grow under the almost ideal condi- 
tions of incubation for 24 hours at 37°C.  in the presence of autolyzing tissue,  and 
hemolytic contaminants can be derived even from the air, at least in Mineola.  One 
large gram-positive "hay bacillus" is strongly lyric on culture under the conditions  of 
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of such a long "latent period" in itself suggests that the lyric material is derived 
from precursors in the tissue. 
The lysin (or lysins) does not diffuse through either collodion or cellophane, 
and  is destroyed by heating  to  60°C.  for 5  minutes.  It has a  pH 9ptimum 
at about 7.1; at pH =  6.5 and 8.1  (phosphate buffers)  some Iytic activity can 
be observed, but at pH 4.5, 5.8, and 8.5 the lysin is apparently inactive.  These 
observations are in agreement with those of Maegraith,  Findlay,  and Martin. 
The point upon which I cannot agree with them is that of the species specificity. 
I have obtained lysis of human cells with pieces of rat lung and lysis of rat ceils 
with pieces of human thyroid, and, in general, have not found  that the lyric 
material affects the cells of the same species  only.  4 
The absence of species specificity puts the matter in a  different light, for if 
we are  dealing  with  a  non-specific lysin we have  to  consider  the  possibility 
that it is lysolecithin or a  substance related to it.  If pieces of rat lung,  etc., 
which prove to be lyric after 12 to 24 hours  are  incubated at 37°C.  in saline 
for 12 hours,  quite large amounts of lysolecithin  (or, more properly, the sub- 
stance identified  as lysolecithin)  can be extracted  from them by the process 
described by Singer (1940)  for the extraction  of lyso]ecithin from serum,  The 
amount is about the same as that contained  in normal human plasma, and it is 
sufficient to produce lysis of a suspension of washed red cells within the second 
12  hours  of the  24  hour  experiment. 5  Since  lysolecithin  is produced  by an 
enzymatic process with a pH optimum of about 7.2,  both the heat sensitivity 
of the tissue lysin, the effect of pH on it,  and, indeed, all of its properties which 
I have observed, would be explainable on the assumption that it is lysolecithin 
or a  related substance.  U  so,  |ysolecithin is probably a  normal intravascular 
lysin produced by the tissues in a  wide-spread manner, and not in the spleen 
only.  Its lyric activity would be dependent on its concentration in the plasma, 
together with the concentration and effectiveness of its plasma inhibitors. 6 
4 An apparent specificity may be due to the cells of one species being less resistant 
to a lysin than the cells of another; e.g., lysolecithin, in sufficient dilution,  would appear 
to be specifically hemolytic for dog cells if its effects were observed on suspensions  of 
the red cells of man and of the dog.  It is possible, of course, that both species-specific 
and non-species-specific lysins are present at the same time, and that sometimes the 
former are so active that the effects of the latter pass unnoticed by comparison.  I 
have never observed this state of affairs.  The question as to the species specificity 
of the tissue lysins played quite an important part in the early history of the subject 
(see Well,  1907), and it was ultimately decided  that the lysins then under discussion, 
at any rate, were non-specific. 
5 The hemoglobin of the hemolytic system may be converted to a brownish deriva- 
tive both by the tissue lysins and by the extracted substances. 
6 A  real difficulty,  however,  lies  in  the smallness  of the  quantity  of lysolecithin 
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IlL  The Nature of the Plasma Inhibitors 
The nature of the inhibitory substances contained in plasma and serum has 
been under investigation ever since the inhibitory effects were first described. 
Both the plasma proteins and the plasma lipoids are inhibitory, and the first 
problem is to find how much of the inhibition is due to the former and how 
much to the latter.  This is a  point on which  observers have held different 
views, some attributing most of the inhibition to the proteins, and others be- 
lieving  that  the  lipoids  are principally responsible.  The  second  question  is 
whether there are diffusible inhibitors  in addition,  for a  powerful inhibitor of 
digitonin hemolysis, the  quantity  of which  is stated to be dependent  on the 
intake of thiamine,  has been recently described (Farley, 1939,  1942;  Horwitz 
and Farley, 1940). 
1.  Inhibition Produced by Plasma Proteins and Lipoids.--There are two ways 
in which  we may identify the  inhibitory substances  and  determine  their in- 
hibitory powers.  The first is to fractionate  the plasma and to measure the 
inhibition produced by the various fractions; the second is to start with pure 
substances, such as serum albumin, fibrinogen, cholesterol, etc., in known con- 
centration,  and to compare the inhibitory effect of each with that  of plasma 
as a whole. 
All  the  inhibitory  substances  of  plasma  seem  to  be  non-diffusible,  and  I 
have been unable to obtain evidence for the existence of the diffusible inhibitors 
described by Farley (see below). 
A partial separation of the constituents of plasma can be effected by adding 
dilute acetic acid to plasma diluted  1 in 10 with saline, until the pH is about 
material extracted from 2 ml. of normal human plasma, after incubation at 37°C. for 
24 hours, in 2 ml. of saline, one obtains a solution 0.2 ml. of which usually completely 
hemolyzes 0.1 ml. of standard red cell suspension  (the thrice washed cells of 1 ml. of 
human blood finally suspended in 20 ml. of saline) in 24 hours in vitro at 37°C.  Now 
Ponder, Hyman, and White (1941) and Ponder and Hyman (1943) have shown that 
the activity of a lysin in a system containing whole blood is very much less than its 
activity in an in vitro system such as this, even when allowances  are made for the 
maintenance of the lysin at a constant level, as it is maintained in vivo.  This rela- 
tively small activity in the system containing whole blood is due to the greater con- 
centration of red cells, to some of the lysin being used up in reacting with the vessel 
walls,  and to the action of the plasma inhibitors.  The inhibitory power of normal 
human plasma for lysolecithin  is such that plasma diluted 1 in 100 gives an R-value of 
between 1.5 and 2.0, and so is of the same order as the inhibitory power for saponin 
or digitonin  hemolysis.  The  extracted lysolecithin  of plasma, a  feeble lysin  even 
in vitro, would therefore be so much feebler in vivo as to raise doubts as to its ability 
to  produce  an  appreciable  degree  of  intravascular  lysis.  Alternatively,  Singer's 
method  may extract  only a  small fraction of the  lysolecithin present  in  plasma, 
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5.0, heating for 15 minutes in boiling water, filtering through paper, and neu- 
tralizing to pH 7.0 with 0.1 N NaOH.  The removal of protein is very complete, 
and the inhibitory power of the filtrate for saponin and digitonin hemolysis is 
only from one-tenth to one-twentieth that of the original plasma.  A variable 
and  surprisingly large  amount  of lipoid, however, is  carried  down with  the 
flocculated protein.  Not realizing this in 1923, I thought that the result of this 
separation was evidence that the greater part of the inhibition is due to the 
plasma  proteins,  and it was  not  until  recently that  I  found the parallelism 
between the inhibitory effect and protein content to be very incomplete (Ponder, 
1943).  By means of the same separation procedure, however, it can be shown 
that only about one-quarter to one-third of the total inhibition of saponin (or 
digitonin)  hemolysis is  due to plasma  cholesterol.  In a  typical experiment, 
the inhibitory power of the plasma for saponin hemolysis is about 16 times that 
of the protein-free filtrate, and the amount of cholesterol in the diluted plasma 
is about 3 times that left in the filtrate.  From these ratios, it appears that the 
plasma protein and the inhibitory substances other than cholesterol which are 
carried down with it are responsible for about 77 per cent of the total inhibition, 
while  the  cholesterol accounts  for the  remaining  23  per  cent.  In  different 
experiments, the figure varies from 20 to 35 per cent. 
Through the kindness of Dr. E. J. Cohn, Dr. H. B. Vickery, and Dr. Hans 
Neurath, I  have obtained a  number of plasma protein fractions in a  state of 
known purity, and have measured their inhibitory power for different lysins. 
In each case the protein, dissolved in a phosphate buffer saline at pH 7.1, was 
introduced  into  a  hemolytic system  containing 0.8  ml.  of lysin,  0.4  ml.  of 
protein in known concentration, 0.4 nil. of sahne, and 0.4 ml. of red cell sus- 
pension, and R-values were found in the usual way.  The principal results are 
shown in Table III, which gives the R-valuestogether with the concentrations 
of protein for which each was obtained. 
It will  be  clear from Table III that  none of the protein fractions has  an 
inhibitory power of the  same order as  that  of plasma  itself.  The most  in- 
hibitory preparation  is  the mixed globulin  Fraction II  +III,  and  this  has 
only 10 to  15 per cent of the inhibitory power of whole plasma.  The horse 
serum albumin and pseudoglobulin, the beef globulin, and the fibrinogen prepa- 
rations exhibit their inhibitory effect, if any, in 1 per cent solution, and so their 
inhibitory power is less than  1 per cent of that of whole plasma.  Since the 
sum of the inhibitory effects of the protein fractions does not amount to more 
than 25 per cent of the total inhibition, ~ and since the cholesterol content ac- 
7 It is quite likely that purification  of the protein fractions alters  their physical 
state in such a way that part of the inhibitory power is lost.  Both Tsai and Lee and I 
have noticed that merely drying the plasma reduces its inhibitory power by 20 to 30 
per cent, and Tsai and Lee attribute this to denaturation.  Since some  of the  in- 
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counts for only about 25 per cent, some 50 per cent of the inhibition has so far 
remained  unaccounted for.  This is also the  conclusion reached by Tsai and 
Lee (1941). 
The position has recently been greatly clarified by the investigations of Lee 
and Tsai (1942 a, b; and see also Tsai and Lee, 1941).  They have approached 
the problem by studying the effect of cholesterol and lecithin sols on hemolysis 
by different lysins  (saponin,  digitonin,  bile  acids and salts,  oleate,  etc.),  and 
have found that lecithin,  although lyric per  se,  enhances the inhibitory effect 
of cholesterol 3 to 10 times in saponin systems.  This enhancement depends on 
the  value  of the  lecithin/cholesterol  ratio  as well as on the  concentration  of 
TABLE III 
Substance 
Human serum albumin* ................ 
Human serum globulin fraction II -[- III~.. 
Horse serum albumin§ .................. 
Horse serum pseudoglobulin[] ............ 
Human fibrinogen ...................... 
Beef serum albumin¶ ................... 
Concen-  [  Saponln 
lr~ti(n 
gin. per  I  c~t  [  R 
O.25  ]  O.95 
0.02  ]  1.11 
1.00  I  0.95 
1.00  1.00 
1.00  1.10 
1.00  1.35 
Digi- 
tonh~ 
R 
0.92 
1.14 
1.35 
1.45 
1.17 
1.00 
Tauro- 
cholate 
R 
1.00 
1.12 
1.80 
1.00 
1.14 
1.75 
Oleate 
R 
1.00 
1.20 
1.45 
1.00 
1.20 
1.35 
* Contained  1 in 1500 merthiolate,  which gives R  =  0.92 with digitonin. 
pure by electrophoresis, the balance being globulins. 
t Also contained  merthiolate.  A mixture of gamma and beta globulins. 
§ Electrophoretically  homogeneous. 
II Electrophoreticaliy  homogeneous. 
¶ Contained 4 per cent globulin impurities. 
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saponin,  and  seems  to  be  due  to  an  interaction  between  the  lecithin,  the 
cholesterol, and the saponin.  A  similar reinforcement is observed in systems 
containing digitonin or the bile salts.  In addition to this,  Lee and Tsai find 
that lecithin per se is inhibitory in saponin, digitonin, and crude bile acid sys- 
tems,  although not in systems containing the bile salts or the oleates.  Their 
evidence  is  sufficient  to  lead  to  the  conclusion  that  the  50  per  cent  of the 
of the system it would not be surprising to find that small changes in physical char- 
acteristics would produce appreciable changes in inhibitory power.  The process of 
purification, moreover, eliminates the enhancing effects of one component on another, 
and it is very doubtful if the sum of the inhibitions  of the purified  components of 
plasma, taken separately, would equal the inhibitory power of plasma itself.  On the 
other hand, all the inhibitory substances acting together would probably produce a 
greater inhibition than that of whole plasma, in which some of the effect of inhibitors 
is offset by the opposed effects of accelerators. 494  Ii~E~rOLYSIS  IN  VIVO 
inhibitory effect of plasma, which has so far remained unaccounted for,  may 
represent the inhibitory effect of the plasma lecithin together with the enhance- 
ment which this substance confers on the cholesterol inhibition.  The sum of 
the  inhibitions produced  by protein,  cholesterol,  and  lecithin,  acting singly, 
together with a  generous allowance for enhancing effects, is  thus  enough  to 
account for the whole inhibitory effect of plasma,  s  The complete elucidation 
of the enhancing  effects  will probably turn  out  to be very difficult, and will 
have  to  take  account  of  the  fact  that  some  of  the  lipoids and  proteins  of 
plasma are actually chemically combined (Bloor,  1943,  p.  185). 
2.  "X-Substance,"  "OBT Principle,"  etc.--Farley  (1939,  1942)  and Horwitz 
s In  connection with  these  inhibitory effects, Lee and  Tsai have  raised the  old 
question as to whether the inhibition takes place in the bulk of the  system, i.e. be- 
tween inhibitor and lysin, or at the red cell surface.  There are two distinct mecha- 
nisms by means of which inhibition can be produced.  In the first, a reaction occurs 
between the lysin and the inhibitor, so that a quantity A of the lysin is rendered inert, 
the original concentrationof lysin Cl falling to a lower concentration c~,  and  A  being 
equal to cl -  c2.  In this case the added cells act merely as an indicator of the amount 
of free lysin.  In the second, the inhibitor acts in the neighborhood of the cell surfaces, 
producing some kind of over-all effect which increases the resistance of the ceils to 
the lysin R times, where R  =  cl/c~.  These two mechanisms may be referred to as the 
A-mechanism and the R-mechanism respectively, and which of the two is operative in 
any given case requires to be decided on experimental grounds. 
In the case of the inhibition of hemolysis (saponin, digitonin, crude bile acid, and 
natural hemolysin) by cholesterol sols, Lee and Tsai have shown that the inhibition 
increases with time and temperature when lysin and cholesterol react in the absence 
of red cells.  This is good evidence for a  A-mechanism.  When cholesterol is added 
to lecithin, oleates, or the bile salts, and when lecithin is added to saponin, digitonin, 
crude bile acid, the bile salts, and the oleates,the inhibition observed when cells are 
added subsequently does not depend on the conditions of either time or temperature 
under which the cells and the inhibitor have stood together.  Lee and Tsai propose 
that in these cases the inhibitors react with the lysins in a  physical rather than  in a 
chemical manner; there remains, however, the possibility that the inhibition is pri- 
marily due to an R-mechanism. 
Both mechanisms are probably coexistent even in the simpler forms of inhibition. 
80 per cent of the inhibition in arginine-saponin systems and 90 per cent of that in 
sucrose-saponin systems, is the result of an  effect on the cells themselves, but the 
remainder may be the result of a  reaction of the inhibitors with the lysin (Ponder, 
1926).  Yeager and I  (1928)  concluded that the inhibitory effect of the sugars is a 
double one both in saponin-sugar-cell systems and in taurocholate-sugar-cell systems, 
an R-mechanism being the more prominent in the case of the former, and a A-mecha- 
nism in the case of the latter.  I  have recently emphasized the effects of the plasma 
inhibitors at cell surfaces, or the R-mechanism (Ponder,  1943) partly because in the 
past I have treated this form of inhibition almost exclusively as a A-mechanism, or in- 
teraction between lysin and inhibitor.  It seems likely, however, that both mecha- 
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and  Farley  (1940)  have described an  inhibitor of digitonin hemolysis which 
they call "X-substance," or "OBT principle."  This inhibitor is stated to be 
present in plasma in quantities which depend on the intake of thiamine or on 
the thiamine level, and Farley has proposed that the inhibitory effect of plasma 
on digitonin hemolysis be used as a method for thiamine assay.  The inhibitory 
power of rabbit plasma  is reported to be enormously increased by the daily 
administration  of  100  mg.  of  thiamine  subcutaneously  for  7  days,  plasma 
initially inhibitory in dilutions of about I in 2000 becoming detectably inhibitory 
in dilutions of about 1 in 1,000,000.  Farley believes that the inhibitory sub- 
stance is of low molecular weight, and related to, if not identical with, another 
inhibitory substance  which he has  obtained in  crystalline form from tissues 
("vitatropin"). 
I have been unable to confirm these results, either as regards the presence of 
a diffusible inhibitor or as regards the alleged effect of thiamine on the inhibitory 
power of serum on digitonin hemolysis.  No measurable quantity of inhibitory 
substance diffuses from serum or plasma through either collodion or cellophane, 
and  I  have not obtained any significant increase in  the inhibitory power of 
serum  or plasma  on digitonin or saponin  hemolysis either in man  or in  the 
rabbit.  In one experiment I gave each of 5 rabbits 100 mg. of thiamine chloride 
subcutaneously daily for a week.  The inhibitory values for the sera, measured 
both by Farley's technique (1942)  and by the method described in part 3 of 
this section, were substantially unchanged.  In another experiment 6 persons 
received 50 mg. of subcutaneous thiamine daily for a  week, and in 2 persons 
the injections were continued for 2 weeks.  No changes in the inhibitory power 
of the sera were observed, other than the small differences which may occur 
from day to day in the untreated animal. 
3.  Variations  in the Inhibitory Power  of Plasma.--Very  few investigations 
have been made on the variations in the inhibitory power of plasma.  When 
investigating them, one may use saponin, digitonin, one of the bile salts,  or 
any other lysin as  the lysin to be inhibited,  and  the results found with one 
lysin need not necessarily be the same as those found with another.  At this 
stage of our knowledge, however, we can suppose that a  general idea of the 
variations in the power of inhibiting intravascular lysins will be provided by 
measurements  of  the  power  of  inhibiting  hemolysins  such  as  saponin  and 
digitonin  in  vitro.  These  lysins,  being  very  stable,  are  more  suitable  for 
quantitative work than are the bile salts or the soaps. 
A  solution of digitonin  9 (or saponin)  is prepared, and decreasing amounts, 
9 Dissolve  100 nag. of 1V~erck's digitonin  in 1000 ml. of saline.  There seems to  be 
some doubt about the solubility of this substance,  which takes a considerable time to 
go into solution.  The exact concentration is not important, but one wants it to be 
such that 1 ml., made up to 1.6 ml. with saline, gives complete lysis of 0.4 ml. of stand- 
ard cell suspension in about 15 seconds.  If lysis is more rapid, the stock solution can 
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1.2 ml.,  1.1  ml.,  ...  0.5 ml., are added to  a  series of tubes.  The volume of 
each is made up to  1.6 ml.  with  saline,  and  the  tubes  are placed in a  water 
bath at 37°C.  1°  To each is added 0.4 ml. of a  red cell suspension  (the thrice 
washed  ceils of 1 ml.  of human blood suspended in 20 ml.  of saline)  and the 
time for complete hemolysis is determined.  The end point with digitonin and 
human  ceils  is  very sharp.  Plotting  the  quantity  of lysin used  against  the 
time required for complete lysis gives a  time-concentration curve.  This curve 
is not always the same for suspensions made from day to day from the blood 
of  the  same  individual,  the  small variations  observed  apparently  reflecting 
small  variations  in  the  resistance  of the  cells  to  digitonin,  such  as  are  also 
found in the resistance of cells to saponin hemolysis (see section IV). 
The sera are obtained by drawing blood from the finger into Wright's tubes 
and  centrifuging.  Each  serum  is  diluted  1  to  500  with  saline  (20  ram. 8 to 
10 ml.).  To each of a  series of  tubes are added  1.2  ml.,  1.1  ml.,  ...  0.5  ml. 
of digitonin, 0.4 ml. of the diluted serum, and enough saline to bring the volumes 
up to  1.6 ml.  The tubes  are  allowed to stand  for a  measured  time  (usually 
1 hour) at room temperature 11 (25°C.), and the time for complete lysis of 0.4 ml. 
10 As in the case of saponin, the asymptotic concentration of digitonin required for 
complete hemolysis increases with increase in temperature.  Thus at  37°C. complete 
lysis is brought about by 0.08 ml. of diluted stock solution of digitonin; at 30°C., 0.09 
ml. is required, at 35°C.,  0.10 ml., and at 40°C.,  0.11 ml.  The sharpness of the end 
point becomes gradually less  as the temperature  rises. 
n The inhibition of digitonin hemolysis by serum and plasma increases with the 
length of time during which the lysin and the inhibitor are allowed to stand together 
before the completion of the hemolytic system by the addition  of the cells.  This 
seems  to be the result of a reaction between cholesterol and other components of the 
plasma and the lysin.  The time course of this reaction has been studied as a function 
of temperature  by Lee and Tsai  (1942 b) for systems containing a variety of  lysins. 
They have found that the inhibitory action of cholesterol for saponin and digitonin 
hemolysis is increased by an increase in temperature,  whereas that for bile salt and 
soap hemolysis is not; the inhibitory effect of lecithin is not affected by temperature 
either.  The time course of the reaction between inhibitor and  lysin is roughly ex- 
ponential, being rapid at first and complete only after some hours.  In the case of the 
inhibition  produced  by plasma,  the  temperature  effect is  small  and  the inhibition 
actually decreases with rise of temperature  (Ponder, 1943).  The time effects are also 
less conspicuous than in the case of inhibition by cholesterol sols, a plasma-digitonin 
system which gives an R-value of 1.37 when the plasma and the digitonin are allowed 
to stand together for 3 minutes before the cells are added giving an R-value of 1.43 
when the reaction is allowed to go on for 30 minutes, and an R-value of 1.51 when it 
continues for 3 hours.  It should not be concluded from this,  however, that the in- 
hibition is entirely due to a reaction between the inhibitor and the lysin in the bulk 
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of  cell  suspension  at  37°C.  is  then  found.  By  comparing  these  times  with 
those on the standard curve, a series of R-values are obtained in the usual way, 
and these, or their average, measure the inhibitory power of the serum.  TM 
Proceeding in this way, we can make a number of observations. 
(a)  The inhibitory power of the serum of normal individuals  varies from day 
to day, e.g. the following R-values were found for one person on 12  consecutive 
days:  1.39,  1.38,  1.35,  1.37,  1.29,  1.20,  1.24,  1.36,  1.39,  1.44,  1.30,  and  1.22. 
There seems to be a  cyclic character to the variations,  the values decreasing 
for a  few days and  then increasing  again.  The variation  in the R-value for 
the  inhibitory  plasma  from  1.20  to  1.44  would have  the  same  effect  in  the 
intact  animal  as a  -4-10  per  cent variation  in the  lysin concentration  in the 
blood stream,  and so would correspond to a  variation of 4-10 per cent in the 
life of the average red cell. 
(b)  The inhibitory power of plasma is not highly correlated either with the 
cholesterol  content  or  with  the  plasma  protein  content.  In  a  series  of  25 
observations,  the coefficient of  correlation  between the R-value and the cho- 
lesterol content was found to be 0.57  =t= 0.14, while that between the R-value 
12 The methods used by Farley for measuring inhibition are not at all satisfactory. 
He first finds the smallest quantity of digitonin required to hemolyze a standard sus- 
pension; this is done by taking 0.9, 0.8,... 0.1 ml. of digitonin of a certain concen- 
tration, adding saline and red cell suspension, and picking out the tube which contains 
the smallest amount of lysin which produces complete hemolysis after 5 minutes at 
40°C.  This amount clearly corresponds to a  quantity a  little greater than c~, the 
asymptote of the digitonin time-dilution curve; but the extent to which it exceeds the 
asymptotic concentration depends on the position of the tube in the series, e.g. if there 
is lysis with 0.9 ml., but not with 0.8 ml., the tube selected contains about 9/8th of 
the asymptotic concentration, whereas if  there is lysis with 0.2 ml. but not with 0.1 
ml.,  the  tube  selected contains about  double  the  asymptotic  concentration.  The 
quantity of lysin to be inhibited  in the part of the experiment which  follows may 
accordingly be variable, in terms of the asymptotic concentration, from experiment to 
experiment.  To the quantity of lysin q selected as a result of this method of titra- 
tion, plasma (or serum) diluted 1 in 1000, or more if necessary, is added in decreasing 
quantities  0.9 ml., 0.8 ml.,... 0.1  ml.  The smallest amount of plasma capable of 
inhibiting the quantity of lysin q is selected, and this measures the inhibitory power 
of the plasma; e.g., inhibition produced in a dilution of 1 in 2000.  What the method 
really measures is the amount of plasma required to inhibit a quantity of lysin (q -  c®), 
and the error of the method lies in the fact that the preliminary titration does not ex- 
actly define what (q  -  c~) is.  For example, if there is no lysis with 0.1 ml., but com- 
plete lysis with 0.2 ml., 0.2 ml. is selected as q; then (q  -  c~) is equal to 0.1.  But so 
far as the titration employed is concerned, q might equally well be 0.19,  or, for that 
matter, 0.11 ml., and  (q -  c,) might really be even as small as 0.01.  Such a  tenfold 
difference in (q -  c~) would correspond to a tenfold difference in the amount of plasma 
required to produce the inhibition, and so the method is far from being an exact one. 498  ~rEMOLYSIS IN VlVO 
and the plasma protein content was 0.55 ±  0.14. TM  This result is to be expected 
in view of Lee and Tsai's demonstration that the inhibitory effects are very 
complicated. 
(c)  Nevertheless,  sharp changes in the cholesterol content or in the plasma 
protein content are usually associated with changes, in the same direction, in 
the R-value, e.g. an R-value of 1.33 was found on one day associated with a 
cholesterol content of 230 rag. per cent, and a fall in the cholesterol content to 
138 rag. per cent on the following day was accompanied by a  decrease in the 
R-value to  1.23  (the  plasma  protein  content remaining  constant  at  7.0  gm. 
per cent).  This associated variation would result from the cholesterol being 
responsible for part of the inhibitory power, but it may be contributed to by 
the same factors which bring about the change in the cholesterol content also 
bringing about a simultaneous change in the concentration of other inhibitors. 
(d)  Under conditions of poor nutrition and after major surgical operations, 
when  the  concentration of protein  and  cholesterol  in  the  plasma  is  usually 
lowered,  the  inhibitory power of the plasma  is very often reduced.  I  have 
already suggested that this reduction in inhibitory power, which would operate 
in the direction of favoring red  cell  destruction by intravascular lysins, may 
contribute to those postoperative anemias which are out of all proportion to 
the amount of blood lost (Seaman and Ponder, 1943). 
IV.  The Steady State and Hemolysis in Vivo 
i 
Suppose  that  the  membrane of the  least  resistant  red  cell  in a  hemolytic 
system contains an amount of a component S and that the lysin acts irreversibly 
on S to convert it into another substance S', 
S +  x --* s'  (1) 
So long as a  certain amount of S  remains in the membrane,  the semipermea- 
bility remains complete, but when a  certain fraction of S  is converted into S / 
the semipermeability is lost. 14  Suppose that this loss  occurs when S' has the 
is I have not been able to obtain as high a correlation between the cholesterol con- 
tent of plasma  and its inhibitory power as some investigators  report.  Tsai and Lee 
(1941) give a correlation coefficient of 0.922 for the inhibitory effect and the cholesterol 
content,  and one of 0.267 for the inhibitory  effect and the protein  content.  Yi and 
lYleng (1941) also conclude that cholesterol is almost  wholly responsible for the in- 
hibitory effects.  My experience agrees more closely with Lee and Tsai's later view 
(1942) that the total inhibitory  effect of plasma is more complex than that produced 
by cholesterol alone. 
14 For simplicity's  sake, one can think of the lysin as digitonin,  and as combining 
with the cholesterol S in the cell membrane to form cholesterol digitonide S r, but the 
situation  is not as simple as this, and,  except as an illustration,  the idea is probably z~ic  Po~Dx~  499 
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particular value So; the loss of semipermeability is the result of the breakdown 
of the membrane at its weakest or least resistant  "key spots" (Ponder,  1941), 
and is followed by an all-or-none hemolysis.  The transformation of S  to S ~ 
corresponds to the utilization of a  quantity of lysin x0,  and the  resistance of 
cell  will  be  properly  defined  by  this  quantity  x0.  Another  cell  of  greater 
resistance x~ will not become semipermeable until a  greater quantity of lysin 
xl is used up in forming compound S'  in  greater  amount S'1;  a  cell  of  still 
greater resistance will not become semipermeable until the still greater quantity 
x~ of lysin has formed the still greater quantity of  compound S~,  and so on. 
If there are N  cells of varying resistance in the system, the distribution of the 
resistances,  each  measured  in  terms  of  the  quantity  of  x  necessary for  the 
breakdown of semipermeability, will be described by some form of frequency 
distribution; i.e., by 
iv =  F(x)  (2) 
In an in  vivo hemolytic system a  concentration of lysin c is maintained at a 
constant level, the lysin used up in reacting with S to form S' being constantly 
replaced by fresh lysin, and so the rate of utilization is constant and propor- 
tional to c, or 
and 
dx/dt  =  k,  (3) 
t  =  x/kc,  or  ~  =  kc.t  (4) 
Let the line AB in Fig. 1 represent the abscissa of the frequency distribution 
of the  cells which are being added to the  circulation from the hematopoietic 
tissues.  The  distribution  itself must be imagined in  a  plane at right  angles 
to the paper, a total number P  being distributed into P0 cells of least resistance 
x0, P1 cells of resistance xl,  ...  P~ cells of mean resistance ~6,, ...  up to Pg 
cells of greatest resistance xg.  Alternatively we can think of the cells as being 
distributed according to the amount of the component S  which each contains; 
thus  the  ceils  of resistance  x0 contain  an amount  of the  component So and 
hemolyze  when  this  is  all  transformed into  S'.  And  so  on  for  the  groups 
Xl  ...  X~  ...  Xg. 
At t  =  0, x  =  0, but as t increases greater and greater quantities of lysin x 
combine with the cell component.  The increase of x with t is represented along 
the  line  BC.  Consider  the  group  of resistance  x0,  starting  when  x  =  0  at 
t  =  0.  As x increases with t, the component So becomes transformed into S', 
misleading.  Many lyric substances have no affinity for cholesterol  of the same sort 
as digitonin has; i.e., do not form known compounds with it, and Tsai and Lee have 
remarked upon the fact that cholesterol  appears to be inhibitory for lysins in general, 
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and  the amount of So which remains is always (x0  -  x)  until the quantity x0 
is  combined  at  the  time  t0.  Then  (x0  -  x0)  ---  0,  and  the  cell  hemolyzes. 
This is expressed  in Fig.  1 by moving the cells of resistance  xo  along the line 
AD,  parallel  to  the  time  axis,  until  they  reach  the  line  DC,  on  which  the 
quantity of component transformed  (xo  on the axis BC) is equal to the quantity 
of component initially present  (x0 or So on the axis AB).  Beyond the line DC 
the  cells  cease  to exist.  In this  case  the length  of the life of the cells  of re- 
sistance x0 in the blood stream will be to. 
Applying the same reasoning to the cells of group &  or to those of anyother 
group, it will be apparent that the course of events is described by moving the 
0 
z=0 
x=0 
A.  13 
xo x  I ..... xm .....  x  5 
FIG. 1.  For explanation, see text. 
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percentage distribution of .P,  erected on the line AB, along the line BC.  As it 
moves,  the  distribution  will  at  first  remain  intact,  bounded  on  the  one  side 
by the line AD and by BC on the other.  At time  to, however, x  on BC will 
become equal  to x0 on OB, and the least resistant  ceils of the distribution,  the 
group x0,  will hemolyze.  Next  the group xl will  hemolyze when  t  =  tl  and 
x  =  xl on BC, and so on for all the other groups  ...  x  ....  xg.  Thus as the 
moving distribution passes over the line DC, that part of it to the left or out- 
side DC will be hemolyzed (e.g.,  when the distribution has reached the position 
EF),  and that part of it to the right or inside DC will be intact.  Eventually 
all of the distribution will lie to the left of DC  and even the most resistant cells 
xg will have hemolyzed.  Throughout, the length of the life in the blood stream 
of any group of cells is the distance from AB to DC, measured parallel to the 
time-axis;  i.e.,  the groups  Xo,  xl,  .  ..  x,~,  ...  x o  have life's to,  tl,  ...  t,,,  ...  t o. EPIC PONDER  501 
Now the solid enclosed as the frequency distribution P,  originally at AB, 
moves over the surface ABCD will represent the total number of cells N  in 
the circulation at any one time.  The form of the frequency distribution of N 
can be found at any moment by appropriate sampling, experiment, and analysis 
(see Ponder, 1934, p. 161).  In the steady state, a number of cells Q must  be 
destroyed to balance the number P  which is added in every interval of time, 
so Q  =  P, and the distribution of Q must be identical with the distribution 
of P.  It will be clear, however, that in order to maintain a given distribution 
of the number N  in the entire solid, the distributions of P  and Q cannot be 
the same as that of N, for P  must contain a  greater proportion of the short 
lived elements and a  smaller proportion of the long lived elements than N 
does.  More specifically, if there are No cells in the group x0 in the distribution 
of N, the number P0 of group x0 in the distribution of P  will be proportional to 
No/to,  to  being,  as before, the life in the  circulation of the cell of group x0. 
Similarly, Pt =  N1/h,  ...  P,,  =  N,,/t,,,  ...  Po =  No/to. 
Several conclusions now follow from these relations between the distributions 
N, P, and Q. 
1.  The distribution of new cells necessary for the maintenance of the popu- 
lation N in its steady state is more negatively skew than the distribution of the 
population N  itself. 
2.  If we withdraw a sample of the population N and determine the resistance 
by adding a  hemolysin, by reducing the tonicity of the medium, or by any 
other standard method, we find the resistances distributed according to the 
distribution N  =  F(x) and the percentage hemolysis curves obtained in experi- 
ment are functions of S F(x). dx.  The resistance of any class of cell, however, 
cannot be interpreted as  a  measure  of its  age,  although a  relation between 
resistance and age is often stated or implied.  The cells of least resistance x0, 
for example,  contain  the  cells of resistance x0 which have  just  entered  the 
population, the cells originally of greater resistance xl which entered at time 
h  previously and whose life time in the blood stream has been h, the cells of 
still greater resistance which entered at time t2 previously and whose age is t~, 
and so on.  The class of cells of greatest resistance, on the other hand, contains 
cells of resistance xo,  and  these must  necessarily be recent additions  to the 
population; it is therefore true that the group of most resistant cells observed 
in  fragility  experiments  is  composed  of  the  "youngest"  cells,  but  equally 
"young" cells are to be found in any other resistance group, and the group of 
the most resistant cells observed in the experiment is certainly not composed 
of the "oldest" cells.  The relation between resistance and age, in fact, is ap- 
parent only at the upper extreme of the frequency curve. 
3.  Since the distributions P  and Q are more negatively skew than the dis- 
tribution N, any sudden change in the rate of production or destruction will 
be reflected in the form of the S-shaped curve N  =  j" F(x). dx which is obtained 502  I~MOLYSlS  IN  VIVO 
by measuring resistance  by the  usual  methods.  These S-shaped  curves are 
difficult to obtain in their entirety and in proper units,  but the resistance of 
the group at the upper extreme is defined by the position of the asymptote of 
the  time-dilution curve.  Slight  variations in  the position  of the  asymptote, 
corresponding to variations in the balance between production and destruction, 
are accordingly to be expected if observations are made daily over long periods, 
and  sufficiently detailed  observations might  even reveal  a  relation  between 
variations in the position of the asymptote and the changes in the value of R 
described in section III, 3.  The changes in the position of the asymptote will 
be familiar to anyone who has plotted time-dilution curves for suspensions of 
his  own red  cells  daily over a  considerable period  of time.  During  the last 
9  years  I  have noticed  variations amounting  to about  -4-10 per  cent  in  the 
position of the asymptote of time-dilution curves for saponin and suspensions 
of my own  red  cells,  and  in  carrying  out  the  experiments  on  inhibition  of 
digitonin  hemolysis described  in  section  III, 3,  I  observed variations  in  the 
position  of the  asymptote of the  digitonin  time-dilution  curve of about  the 
same magnitude. 
ii 
Let us next consider how the total number of cells in the population N  de- 
pends on the numbers in the population P  and Q.  N  is the number of cells 
in the circulatory system, and there is a process producing new cells at a  con- 
stant rate P.  There is also another process removing the cells at a rate which 
must be proportional to N  and which may also vary explicitly with the time t. 
Let the  rate of removal be denoted  by Nf,  where f  may be a  function  of t; 
f may be called the "fractional rate of removal."  The general problem is to 
find the value of N  at any time t, given the initial value. 15 
The net rate of increase dN/dl is the difference between P,  the rate of pro- 
duction,  and Nf,  the rate of removal, so 
aN/at  =  2,-  NI  (S) 
Let 
If.at  =  F  (6) 
where F is a function of ¢ which may be found by integration when the function 
f  is given. 
The solution of the differential equation (5) is 
~v =  (k +  t" I  d'.at) .e'r  (7) 
where k is a  constant determined by the initial conditions.  The value of this 
result is that it gives us the solution of the problem for any variation in the 
151 have to thank Dr. R. T. Cox for the general and special solutions  in this sec- 
tion, as weU as for the development of a satisfactory method of analyzing the experi- 
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rate of fractional removal, provided that the two integrals f f.dt and J" e  v. dt 
can be evaluated. 
Special Solution  1:  Constant  Fractional  Rate  of RemovaL--If  the fractional 
rate of removal is constant, f  =  a, and 
If.dr  =  f  a.dt  =  F  =  at  (8) 
] e~.dt  =  ] eat.dr  =  1.eat  (9) 
Substituting in equation (7), 
N  =  (k+P.eat).e  "-at  (10) 
When t =  O, let N  =  No; then k  =  No -  P/a, and so 
N  -=  (No--  P).e-at-i-  P/a  (11) 
The first right-hand term approaches zero as t increases, and so N  approaches 
a  steady state with a  value P/a.  As the term does not change sign,  if the 
value of N  is initially above the steady state,  No  --  P/a is positive and N 
never becomes less than P/a.  Similarly if N  has an initial value below the 
steady-state value, it never exceeds P/a.  If N  is initially equal to P/a,  it 
never varies. 
Special  Solution  2:  Uniformly  Increasing  or  Decreasing  Fractional  Rate  of 
Removal.--Let f  =  a +  bt; then 
f f.dt  =  !  (a +  bt) dt =  F  =  at +  ½bt  ~  (12) 
The integral f  e  r.dt cannot  be  evaluated  precisely, but the integration can 
be performed by regarding gt+~bt2 as an infinite series 
1 +  (at +  }bt ~)  +  ½(at -4- ½bt~)  '  +  ½(at -4- bt2)'... 
Expanding by the binomial theorem and collecting terms in each power of t, 
we get 
@t+~t'  =  1 +  at+½(b+a~)l'+~(ab+  a-a-~)t  8 
V  °:) 
-1- ~  -~ .4- a'b .+  t~ .+  ... 
Hence 
S d"dt  =  t  "4- ½at  2 +  ~(b +  a2)t  3 -4- ~  ab -4-  t 4 
°')  +  -~+a~b+-~  t~+... 
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This expression vanishes when t  =  0; also, when t  =  0, e  -v =  1.  Referring 
to equation  (7), we see that when t  =  0, N  =  k, so No may be written for k. 
Substituting  in  (7)  the  values of F  and  of f  e~'.dt given by  (12)  and  (13), 
we have 
[  {,  }3 
1V  =  No +  P  +  ½at~ +  ~(b +  a~)t  ~ -Jr ~  ob  "4-  t 4 ....  e  ''at'4btj  (14) 
Equations  (11) and (14) can be combined to give the values of N  in any case 
in which  the  graph of f  against  t  is made  up of straight  segments.  At any 
junction of two segments of the graph, the final value of N  on the first segment 
is  taken  as  the  initial  value  No  on  the  second  segment.  A  few  examples 
follow. 
Special Solution 3:  Abrupt Transition between Two Constant Values off.--Let 
f  be constant for a  long time at a value a' and then at a  certain instant tl let 
it change instantaneously to a  higher value a"  (see Fig.  2, A).  At 6  and for 
some  time before we may assume  that  N  is at  its steady state value P/a'. 
Whenf suddenly assumes the new value a", equilibrium is destroyed and sub- 
sequent values of N  are given by equation (11), the time t being reckoned from 
tl, the instant of transition, so that P/a' replaces No and a" replaces a'.  The 
graph of N  against t  is shown  in  Fig.  2,  B.  The  break in  the slope  of the 
graph corresponds to the change in dN/dt as f  changes from a' to a". 
Special Solution 4: Gradual Uniform Trans#ion  between Two Constant Values 
off.--Let f  be constant for a  long time at a value a'.  At a  time tl let it start 
to increase linearly and let it attain a  new value a;' at an instant #~ and there- 
after remain constant  (Fig. 2, C).  This case differs from the one just treated 
in that here dN/dt does not change discontinuously; consequently there will be 
no sharp break in the slope of the graph of N  against t. 
The value of N  at 6 and for some time previously is P/a'.  Beginning at 6, 
equation  (14)  is  used,  with  time reckoned from the  instant  6  as zero,  P/a' 
replacing No, a' replacing a, and (a" -- a')/(t2  -- tl) replacing b.  This solution 
is  valid  until  the  instant  t~,  at  which f  becomes constant  at  the  value  a".  ~8 
The value found for N  at & now becomes No in equation  (11),  in which  the 
time is reckoned from the instant t~ as zero and in which a" replaces a.  The 
form of the graph of N  against t is shown in Fig. 2, D. 
Special Solution 5: Linear Rise and Fall of  f.--Let there be initially a  steady 
state characterized by a  constant  value a' of f.  At the instant  6  let f  start 
to rise uniformly, attaining a value a" at the instant t~.  Now letfstart falling, 
and  let  it  attain  the  value  a' again  at  the  instant  ta,  remaining  constant 
thereafter.  Let t3 -  t~ =  t: -- h, the rate of fall being equal to the rate of rise. 
xn The instant at which/assumes its new value often corresponds  to a point of in- 
flection on the experimental curve of N against t, but a point of inflection may occur 
under some circumstances while/is uniformly increasing. ERIC PONDER  505 
In this case the solution up to the time ~ is the same as that given in Fig. 2, D. 
From ~ to ta the variation of N  is given by equation (14) with time reckoned 
tN 
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FIG. 2.  Curves illustrative of special solutions  3, 4, and 5.  Ordinates,  N  and f; 
abscissa,  time.  Solid curves show variations in f; dotted curves show variations in 
N.  For explanation,  see text. 
from t~, with b  =  -(a"  -  a')/(t3  --  t~),  with a replaced by a", and with the 
value of N  at a being taken as No.  After is, equation (11) is again used, with 
time reckoned from ta, so that No is the value of N  obtained at t~.  Also a' 
replaces a.  Graphs corresponding to this special solution are shown in Fig. 2, 
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The Analysis of Experimental Curves.--The general method of dealing with 
experimental  curves  which  show  the  variation  of  N  with  time  can  best  be 
illustrated  by  the  analysis  of  a  curve  such  as  that  shown  in  Fig.  3,  which 
represents the changes in the red cell count observed during the first  15 days 
of the development of a hemolytic anemia due to the administration of phenyl- 
hydrazine.  The  method  requires  that  somewhere the  system passes from a 
changing state to a steady one, or to one so nearly steady that one can estimate 
5 
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FIG. 3.  Analysis of a curve for the fall in the red cell count N  after administration 
of phenylhydrazine.  See text for further description. 
a  steady-state value of N.  In Fig. 3,  a  steady state seems to be attained at 
about  15  days,  for which  N  =  1.05.  Since  in  general  dN/dt  =  P  --  Nf 
(expression 5),  and  since dN/dt  =  0  in  the  steady state,  N  =  P/f,  and  so 
P/f =  1.05, f  being the fractional rate of removal in the steady state.  Now 
in the approach to this steady state, f  must have been constant for some time, 
or else the steady state would never have been reached; and whenf is constant, 
we can find N  as a function of the time t.  We have 
dN/dt  =  P-  Nf,  o,  aN  =  -f(~-  P/:) d:  (15) 
Since P  and fare constant, d(P/f) =  0, and we may replace dN by d(N -- _P/f). 
So we have 
d(¢¢  -  P//) 
-.f .at  (16) 
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which gives on integration 
(iV -  P/y), 
y(t, -  t)  =  log  iv -  P/y  (tT) 
where tl is any specific value of the  time t  and  (N  -  P/f)l is  the value of 
N  -  P/f at that instant.  In the specific case of Fig. 3, we have P/f =  1.05, so 
(N-  1.05)1 
f(tl  --  t)  =  2.3 logm 
N-  1.05 
We now plot (N  -  1.05)i against t on semi-log paper, and see how far back 
on the curve f  is constant  (Fig. 3,  inset a).  From 5  to  I0 days, one gets a 
good straight line, and the value of f  turns out to be 0.41. 
To find the value of f  at  times before 5  days,  we first find P,  and  since 
P/f =  1.05 andf =  0.41, P must be 0.43.  Now using expression (5) in the form 
P  --  dN/dt 
f  (18)  N 
we draw tangents of slope dN/dt to the experimental curve.  With values of N 
taken from the curve at the points where the tangents are drawn,  and with 
the value 0.43 inserted for P  in expression (18), the value of f  can be found 
for any time t.  Fig, 3, inset b, shows the way in which f  varies with t; for 
the first 4 days the fractional rate of removal rises almost linearly, and then 
becomes virtually constant at about 4 times its initial value. 
Figs.  4  and  5  show two other examples of experimental curves and  their 
analysis by this  method.  The data  for Fig.  4  are  taken from Ponder and 
Abels (1936), and show the fall in N  following the injection of 80 rag. per kilo 
per day of quinine hydrochloride into a rabbit.  In this very simple case, the 
fractional rate of removal seems almost immediately to assume its new value 
(see inset of Fig. 4).  The data for Fig. 5 are taken from the paper by Dziemian 
(1942) on the effect of the injection of phenylhydrazine on the red cells of the 
rabbit,  and  show the result  of a  single  injection.  Here the  value of f  first 
rises and then falls to a level even lower than that for the normal steady state 
(see inset of Fig. 5).  This probably means, in reality, that the increased rate 
of destruction has been followed by an increased rate of production. 
... 
In the foregoing analysis, the total number of red cells in circulation is de- 
termined in terms of the rate of production P  and the rate of destruction Q 
or Nf.  If the process of destruction is an in vivo hemolytic process, some of 
the factors which control it can be specified further. 
As expressed in equation (1), the rate of the fundamental lyric reaction by 
means of which the removal of cells is effected is proportional to c, and in the ~]p,a,  J  f 
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FIG. 4. Analysis of a curve for the fall in the red cell count following  administration 
of quinine (data of Ponder and Abels, 1936).  See text for further description. 
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FIG. 5.  Analysis of a curve for the changes in the red cell count after administra- 
tion of phenylhydrazine (data of Dziemian, 1942).  See text for further description. 
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steady state f  has some special value  (a in expression  (8))  which makes the 
rate of red cell destruction equal to the rate of production.  If c changes from 
one value Co to another cl, then Co~C1 =  R,  and f  changes from a  to al, where 
al  =  aiR.  Such a  change in the value of c can occur in two principal ways. 
1.  The rate of production of lysin may increase, as after a meal of fat, when 
the concentration of soaps in the blood stream rises.  Many other instances of 
an increase in the concentration of intravascular lysins are known, particularly 
in pathological conditions. 
2.  Although  the rate of production of lysin remains constant,  the  effective 
concentration of lysin in the blood stream may increase because of the addition 
of accelerators or the removal of inhibitors.  In the normal steady state the 
concentration  of lysin is kept at a  certain effective value by the mixture of 
plasma accelerators and inhibitors, the net effect of which is an inhibitory one. 
For convenience, let us use the steady-state system as the standard one.  If 
the net inhibitory power of the plasma decreases, so that R becomes less than 
unity with reference to the inhibitory power in the steady state, the effective 
concentration  of lysin,  which  was  c0  originally,  will  increase  to  co~R,  The 
net inhibitory power of the plasma may decrease, of course, either by the de- 
crease in the quantity of the inhibitors or by an increase in the quantity of the 
accelerators, and in this way the effective concentration of lysin can undergo 
wide variations, especially in the direction of increasing. 1~  The way in which 
the net inhibition R~ depends on the individual inhibitions R~ and accelera- 
tions R~ has been discussed in the first section of this paper, and it is probably 
generally true that the inhibition or acceleration produced by any individual 
substance is roughly proportional to its quantity (see Ponder, 1939, 1941, 1943). 
The analysis as outlined above requires in addition that P  remains constant, 
and since this is a  requirement which is not always fulfilled in actual experi- 
ence, experimental curves should be analyzed in this way only when it is reason- 
able to believe that the change in N is due to changes in the extent of a destruc- 
tive (usually hemolytic) process.  For a more complete understanding of what 
occurs during the development of an anemia and recovery from it we would 
1~ It is very noticeable that there are many ways in which the red cell count can 
be reduced to a lower level, but only a few in which it can be raised above the normal 
steady state.  Under no circumstances can it be raised very much, and in the few 
cases in which increases are observed they tend to be brought about at the expense of 
red cell size; i.e., the quantity of reactive material, from the point of view of a  hemo- 
lytic system, tends to remain constant.  This suggests that there is a mechanism, not 
considered  here,  which  becomes  operative  when  the  normal  level  is  exceeded. 
Decreases in the concentration of intravascular lysins below the normal steady-state 
values, and increases  in the net inhibitory power of the plasma above the normal 
steady-state values, either do not occur or are ineffective  because the normal steady 
state constitutes a "ceiling state" in the physiology of the intact animal. 510  I:LEMOLY$IS IN  VIVO 
have to have some method of measuring variations in either P  or Q independ- 
ently.  An indication, but not necessarily an exact measure,  of variations in 
the latter would be provided by the urobilinogen excretion.  This is certainly 
not a  very satisfactory state  of affairs;  taken together with  the  great  diffi- 
culty  in  extracting  in  viw  lysins  quantitatively  and  the  uncertainty  with 
which the occurrences in  complex hemolytic systems can be approached from 
the  study  of  the  effects  of  their  isolated  components,  it  probably  means 
that the kinetics of in vivo hemolysis can be established in specially selected 
cases  only. 
SUMMARY 
This paper is concerned with a variety of questions which bear on the occur- 
rence of hemolysis in vivo, and with the possibility of regarding the contents 
of the blood stream as a hemolytic system in which a steady state is maintained 
by the production of new red cells to replace those which are destroyed.  The 
material which is dealt with includes the following. 
1.  Mixtures of Lysins, Accelerators, and Inhibitors.--The effects of individual 
accelerators and inhibitors in mixtures, like the effects of individual lysins, are 
roughly additive in simple  systems,  the  acceleration or inhibition  produced 
by  the  individual  substances  being most conveniently measured in terms of 
R-values. 
2.  Normal Intravascular  Lysins.--These probably play only a  small part in 
red cell destruction unless their concentration rises to unusual levels, or unless 
their effects are enhanced by accelerators, or by the reduction of the concen- 
tration of normal  inhibitors.  The three  normal in vivo hemolytic processes 
for which there is substantial evidence involve (a) the action of the bile salts 
and of the soaps derived from chyle, (b) the action of the spleen, and (c) the 
action of hemolytic substances derived from tissues.  The recent observations 
of Maegraith, Findlay, and Martin on the presence of widely distributed tissue 
lysins are confirmed except for their conclusion that  these lysins are species- 
specific.  Species-specific tissue lysins, if present, are not  the only lysins de- 
rivable from tissues by simple immersion in saline, for non-species-specific lyric 
substances can also be obtained, and seem to be similar to the "lysolecithin" 
which some regard as responsible for the action of the spleen on red cell fragility 
and shape. 
3.  Plasma Inhibitors.--About  30 per cent of the  total inhibitory effect of 
plasma for saponin hemolysis is due to the contained cholesterol, while 25 per 
cent at most is due to the plasma  proteins, particularly globulins.  The re- 
maining 45 per cent is probably accounted for by enhancing effects among the 
inhibitors; e.g.,  the enhancing effect of lecithin on the cholesterol inhibition. 
The mechanism  of the inhibition is  still  incompletely understood; probably 
reactions  between  inhibitor  and  lysin  and  reactions  between  inhibitor  and ERIC PONDER  511 
components of the red cell surface are both involved, and it is important to 
observe that the inhibitory effect of plasma or of a plasma constituent may be 
greater in systems containing one lysin than in systems containing another. 
No evidence for diffusible inhibitory substances in plasma has been found, and 
the variations observed in the inhibitory power of human plasma seem to be 
related to the  combined concentrations of cholesterol, protein, and probably 
lecithin,  rather  than  to  the  cholesterol  content alone.  For  this  reason  the 
inhibitory power tends to be low under conditions of poor nutrition. 
4.  The Steady State and the Kinetics of Hemolysis In Vivo.--On the assump- 
tion that the steady state is the result of a  balance between a  process which 
produces red cells  and a  process which destroys them, equations have been 
developed for the way in which cells of different resistances are affected when 
the rate of destruction changes.  A method for analyzing experimental curves 
is described and illustrated.  In general, this part of the paper relates the level 
of the red cell count in the animal to the intensity of the hemolytic processes 
taking place in vivo, and does not lend itself to detailed abstraction. 
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